Navigation Links
InterMune Reports First Quarter 2013 Financial Results and Business Highlights
Date:4/24/2013

mid-June 2013.  The price of Esbriet in Italy will be announced at the time of the publication.  In Italy, up to nine months are needed after a new product is launched to address the various regional access procedures before patient access to the product is achieved in every region.  
  • On March 20, 2013, the health technology appraisal body in England and Wales, NICE, recommended Esbriet® (pirfenidone) for treating IPF patients whose predicted forced vital capacity (FVC) is between 50 percent and 80 percent at the initiation of therapy.  The Final Appraisal Determination (FAD) recommends the prescription of Esbriet as long as InterMune makes the Patient Access Scheme (PAS) available.  The PAS is a confidential pricing and access agreement with the UK's Department of Health.  The NHS list price for Esbriet is £26,100 per full year of treatment.  At current rates of exchange this is equivalent to roughly $39,770 per patient per year.  According to the regulations in England, up to 90 days from the publication of the final guidance are required before a new product may be reimbursed in England.  Since the official publication of the final NICE guidance occurred today, the company currently plans to launch Esbriet by or before the middle of August.
  • Update on Other EU Countries -- InterMune currently expects to conclude pricing and reimbursement discussions in Ireland in June and if acceptable terms are agreed, to launch Esbriet in the third quarter.  Regarding the remaining two of the company's 15 top-priority European countries, Spain and the Netherlands, economic conditions in Spain and healthcare system changes in the Netherlands make it challenging to predict the date by which a company can expect to conclude pricing and reimbursement for a new product.  The company currently expects to provide an update on the pricing and reimbursement discussions on E
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
    2. InterMune to Present at J. P. Morgan Healthcare Conference
    3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
    4. InterMune To Present At JMP Securities Healthcare Conference
    5. InterMune To Release Third Quarter Financial Results On November 7
    6. InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
    7. InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights
    8. InterMune To Release First Quarter Financial Results On April 24
    9. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    10. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    11. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/27/2014)... (PRWEB) October 27, 2014 The ... Management, Intelligent Traffic Management, Communication, Monitoring), and by ... Forecast to 2019” segments the global market into ... revenues. It also identifies the drivers and restraints ... and challenges. , Browse 75 market tables and ...
    (Date:10/27/2014)... Investor-Edge has initiated coverage on ... NBIX ), Insmed Inc. (NASDAQ: INSM ), ... Corporation (NASDAQ: DYAX ), and Oncothyreon Inc. ... be accessed at: http://investor-edge.com/register . On ... 4,483.72, up 0.69%, the Dow Jones Industrial Average advanced ...
    (Date:10/25/2014)... 25, 2014 The report “Adipic ... by Geography - Global Trends & Forecast to ... respect to market drivers, opportunities, and trends in ... and 27 figures spread through 217 slides and ... Trends & Forecast to 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , ...
    (Date:10/25/2014)... 24, 2014 According to new ... Data Center Types (Colocation, Enterprise, Telecom), by Design ... 1, Tier 2, Tier 3, Tier 4) - ... and segments the Data Center Construction Market into ... of revenues. This research report also identifies the ...
    Breaking Biology Technology:Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 2Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 3Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4
    ... ... The global Nanomedicine market continues to register robust growth largely fueled by unique properties ... in funding across the globe, and increased hype around nanotechnology. , ... San Jose, CA (PRWEB) June 25, ...
    ... will offer expanded access to choice, quality and cost-efficiency ... and AVENTURA, Fla., June 24 Galichia Heart Hospital ... for Galichia to host MSI-coordinated, highly specialized, urologic surgical ... immediately, expands Galichia,s capabilities as a center of excellence ...
    ... 24 Kewaunee Scientific Corporation (Nasdaq: KEQU ) ... fiscal year ended April 30, 2009. , , ... $1.66 per diluted share, up from net earnings of $3,134,000, ... Earnings benefited from higher sales volume, lower manufacturing costs and ...
    Cached Biology Technology:World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM) 2Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM) 3Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16% 2Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16% 3Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16% 4Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16% 5
    (Date:10/29/2014)... LANSING, Mich. – As bodies decompose, their types ... the clues they provide could mean the difference ... , Michigan State University is using a more ... help Detroit death-scene investigators examine these changing populations. ... as geographical location of death, gender, race, socioeconomic ...
    (Date:10/29/2014)... the living world compete with members of their ... much they invest into their competitive ability. Some ... access to high-quality resources, while others seem to ... lower-quality resources that are left over for them. ... human societies seems to fluctuate considerably over time. ...
    (Date:10/28/2014)... in German . ... acquire sufficient food when times are lean? By studying ... d,Ivoire researchers of the Max Planck Institute for Evolutionary ... how great apes can acquire extra energy needed to ... their sleeping nests more en route to breakfast sites ...
    Breaking Biology News(10 mins):MSU partners with Detroit to investigate death scenes 2Evolution of competitiveness 2Evolution of competitiveness 3The early chimp gets the fig 2The early chimp gets the fig 3
    ... In order to reduce the Province,s greenhouse gas emissions, the ... renewable biofuels such as ethanol, from biomass grown in BC. ... other food products continues to raise concerns about impact on ... a source of next generation renewable biofuels. In the ...
    ... August 23, 2009 Case Western Reserve University School ... Molecular Biology, Jeff Coller, Ph.D., and his team discovered ... altering a common understanding of how gene expression is ... in Saccharomyces cerevisiae ", is published in the ...
    ... WEST CHESTER, Pa., Aug. 4 ComCam International, Inc. ... control products, solutions and services, today announced that it has ... software and systems integration for a Maritime Domain Awareness and ... CEO Don Gilbreath stated, "Our two companies have worked informally ...
    Cached Biology News:New genomic research to tackle supply and demand issues in emerging forestry biofuels industry 2New genomic research to tackle supply and demand issues in emerging forestry biofuels industry 3Case Western Reserve University researcher demonstrates that messenger RNA are lost in translation 2ComCam Selected by ePortation on New Maritime Domain Awareness Project 2
    Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
    Request Info...
    ... Our entry-level automated perfusion system. For ... perfusion, physiology, biophysics, electrochemistry, or general ... with 10 millisecond accuracy Run ... Microprocessor-based for accuracy and flexibility ...
    Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
    Biology Products: